FB 849
Alternative Names: FB-849Latest Information Update: 28 Apr 2026
At a glance
- Originator 1St Biotherapeutics
- Class Antineoplastics; Small molecules
- Mechanism of Action Hematopoietic progenitor kinase 1 modulators
-
Orphan Drug Status
No
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Phase I/II Solid tumours
- No development reported Cancer
Most Recent Events
- 28 Apr 2026 No recent reports of development identified for phase-I development in Cancer in South Korea
- 25 Apr 2025 Pharmacodynamics data from preclinical trial in Cancer presented at the 116th Annual Meeting of the American Association for Cancer Research (AACR-2025)
- 05 Apr 2024 Pharmacodynamics data from a preclinical studies in Cancer presented at the 115th Annual Meeting of the American Association for Cancer Research, 2024 (AACR-2024)